Synovus Financial’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,698
| Closed | -$2.49M | – | 848 |
|
|
2023
Q3 | $2.49M | Buy |
5,698
+326
| +6% | +$163K | 0.03% | 306 |
|
|
2023
Q2 | $2.7M | Sell |
5,372
-406
| -7% | -$195K | 0.03% | 299 |
|
|
2023
Q1 | $2.89M | Sell |
5,778
-1,665
| -22% | -$797K | 0.03% | 276 |
|
|
2022
Q4 | $3.04M | Buy |
7,443
+97
| +1% | +$37.7K | 0.03% | 268 |
|
|
2022
Q3 | $2.4M | Buy |
7,346
+367
| +5% | +$135K | 0.03% | 288 |
|
|
2022
Q2 | $2.45M | Buy |
6,979
+149
| +2% | +$60.8K | 0.03% | 278 |
|
|
2022
Q1 | $3.73M | Buy |
6,830
+352
| +5% | +$185K | 0.04% | 227 |
|
|
2021
Q4 | $4.27M | Sell |
6,478
-26
| -0.4% | -$16.3K | 0.04% | 218 |
|
|
2021
Q3 | $4.05M | Sell |
6,504
-2,931
| -31% | -$1.97M | 0.04% | 206 |
|
|
2021
Q2 | $5.96M | Sell |
9,435
-145
| -2% | -$80.1K | 0.06% | 166 |
|
|
2021
Q1 | $4.69M | Buy |
9,580
+632
| +7% | +$317K | 0.05% | 176 |
|
|
2020
Q4 | $4.44M | Buy |
8,948
+421
| +5% | +$188K | 0.05% | 174 |
|
|
2020
Q3 | $3.35M | Sell |
8,527
-337
| -4% | -$125K | 0.04% | 193 |
|
|
2020
Q2 | $2.93M | Buy |
8,864
+287
| +3% | +$83.1K | 0.04% | 193 |
|
|
2020
Q1 | $2.07M | Buy |
8,577
+7,889
| +1,147% | +$2.06M | 0.03% | 257 |
|
|
2019
Q4 | $181K | Sell |
688
-1,207
| -64% | -$318K | ﹤0.01% | 701 |
|
|
2019
Q3 | $518K | Buy |
1,895
+37
| +2% | +$10.3K | 0.01% | 455 |
|
|
2019
Q2 | $511K | Sell |
1,858
-733
| -28% | -$181K | 0.01% | 453 |
|
|
2019
Q1 | $583K | Buy |
2,591
+81
| +3% | +$16.7K | 0.01% | 420 |
|
|
2018
Q4 | $468K | Sell |
2,510
-27
| -1% | -$5.54K | 0.01% | 433 |
|
|
2018
Q3 | $629K | Buy |
2,537
+264
| +12% | +$64.1K | 0.01% | 421 |
|
|
2018
Q2 | $497K | Sell |
2,273
-46
| -2% | -$9.48K | 0.01% | 433 |
|
|
2018
Q1 | $442K | Sell |
2,319
-131
| -5% | -$24.2K | 0.01% | 451 |
|
|
2017
Q4 | $384K | Sell |
2,450
-205
| -8% | -$32.3K | 0.01% | 456 |
|
|
2017
Q3 | $408K | Buy |
2,655
+406
| +18% | +$64.2K | 0.01% | 437 |
|
|
2017
Q2 | $361K | Buy |
2,249
+61
| +3% | +$9.91K | 0.01% | 467 |
|
|
2017
Q1 | $336K | Buy |
2,188
+200
| +10% | +$27.6K | 0.01% | 436 |
|
|
2016
Q4 | $233K | Buy |
1,988
+1,498
| +306% | +$171K | 0.01% | 479 |
|
|
2016
Q3 | $55K | Hold |
490
| – | – | ﹤0.01% | 692 |
|
|
2016
Q2 | $46K | Hold |
490
| – | – | ﹤0.01% | 671 |
|
|
2016
Q1 | $38K | Hold |
490
| – | – | ﹤0.01% | 685 |
|
|
2015
Q4 | $36K | Hold |
490
| – | – | ﹤0.01% | 699 |
|
|
2015
Q3 | $36K | Hold |
490
| – | – | ﹤0.01% | 660 |
|
|
2015
Q2 | $31K | Hold |
490
| – | – | ﹤0.01% | 664 |
|
|
2015
Q1 | $38K | Buy |
490
+178
| +57% | +$13.9K | ﹤0.01% | 674 |
|
|
2014
Q4 | $23K | Hold |
312
| – | – | ﹤0.01% | 747 |
|
|
2014
Q3 | $18K | Buy |
+312
| New | +$19.7K | ﹤0.01% | 756 |
|
Other funds holding IDXX
Synovus Financial's IDXX Position: Q4 2023 in Review
Synovus Financial sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 5,698 shares — an estimated $2.49M sold.
Synovus Financial first reported a position in IDXX in Q3 2014 and held it in 37 quarters. The position peaked at $5.96M in Q2 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.
- Synovus Financial reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
- Synovus Financial sold 5,698 Idexx Laboratories shares in Q4 2023, an estimated $2.49M.
- Synovus Financial first reported a position in Idexx Laboratories in Q3 2014 and held it in 37 quarters.
- Synovus Financial's Idexx Laboratories position peaked at $5.96M in Q2 2021.
- 1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.
Based on Synovus Financial's 13F filing for Q4 2023, filed 14 Feb 2024.